JCIA
JAZZ icon

Jackson Creek Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jackson Creek Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
+7,510
New +$1.31M 0.42% 116
2023
Q4 		– Sell
-5,039
Closed -$652K – 332
2023
Q3 		$652K Buy
+5,039
New +$671K 0.28% 193
2023
Q1 		– Sell
-3,424
Closed -$545K – 336
2022
Q4 		$545K Buy
+3,424
New +$502K 0.24% 219

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jackson Creek Investment Advisors's JAZZ Position: Q1 2026 in Review

Jackson Creek Investment Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 7,510 shares worth $1.42M. The stake represents 0.42% of the portfolio and ranks #116 among its holdings. This is a return to the name: Jackson Creek Investment Advisors previously reported a position in JAZZ as recently as Q3 2023.

Jackson Creek Investment Advisors first reported a position in JAZZ in Q4 2022 and has held it in 3 quarters since. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Jackson Creek Investment Advisors held 7,510 shares of Jazz Pharmaceuticals worth $1.42M as of Q1 2026.
  • Jazz Pharmaceuticals was a new Jackson Creek Investment Advisors position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.42% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #116 holding.
  • Jackson Creek Investment Advisors first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 3 quarters since.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.